RAP 0.00% 20.5¢ raptor resources limited

Excellent clinic evaluation results which will start to generate...

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
  1. 27,253 Posts.
    lightbulb Created with Sketch. 1765
    Excellent clinic evaluation results which will start to generate revenue of ResAppDx into this sector and Medgate signing up as the first telehealth provider in Europe, these are all due in 3 months and push the pps back to 20c IMO.
    RAP is a very unique product which doesn't have any technology limitation since this is totally objective so the doctors can't do what the product does. Hence, there are no other alternate stock in this sector which RAP provide, especially one that has all age demographic market which mean a massive revenue potential covering all the medical field in telehealth, clinic and ED and later DTC.
    Last edited by AlCp: 10/02/21
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.